162 related articles for article (PubMed ID: 404744)
1. [Treatment of pyknoleptic petit mal epilepsy and juvenile myoclonic epilepsy with dipropyl acetate (Deprakine). A pilot study of therapy-resistant patients during control of plasma concentration].
Schroll M; Naestoft J; Lund M
Ugeskr Laeger; 1977 May; 139(18):1073-7. PubMed ID: 404744
[No Abstract] [Full Text] [Related]
2. [The treatment of primary generalized epilepsies with dipropyl acetate (DPA)].
Lagenstein I; Blaschke-Zimmermann E; Iffland E; Sternowsky HJ; Fehr R
Fortschr Med; 1977 Apr; 95(13):892-6. PubMed ID: 403114
[TBL] [Abstract][Full Text] [Related]
3. [Sodium di-n-propylacetate, effect in the treatment of resistant epilepsy. A controlled study].
Gram L; Wulff K; Rasmussen KE; Flachs H; Würtz-Jørgensen A; Sommerbeck KW; Løhren V
Ugeskr Laeger; 1977 May; 139(18):1064-9. PubMed ID: 324058
[No Abstract] [Full Text] [Related]
4. Sodium valproate for the treatment of childhood epilepsies.
Silberstein P
Med J Aust; 1977 Jan; 1(4):95, 98-9. PubMed ID: 403393
[TBL] [Abstract][Full Text] [Related]
5. [Epilepsy with myoclonic absences].
Salas Puig J; Acebes A; González C; Tuñón A; Guisasola LM; Lahoz CH
Neurologia; 1990; 5(7):242-5. PubMed ID: 2126943
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic results with sodium dipropylacetate in infantile myoclonus epilepsy].
Papini M; Martinetti MG; Guerri S; Pasquinelli A
Riv Neurol; 1976; 46(6):503-7. PubMed ID: 827804
[No Abstract] [Full Text] [Related]
7. [Trial of a new antiepileptic drug, magnesium dipropyl acetate].
de Pasquet EG; Gomensoro JB; de Bustos LF; Tenzer SM
Acta Neurol Latinoam; 1973; 19(1-4):119-28. PubMed ID: 4619958
[No Abstract] [Full Text] [Related]
8. [Valproic acid -- clinical efficiency and serum concentration in the treatment of petit mal epilepsy in childhood (author's transl)].
Fritsch G; Haidvogl M; Gleispach H; Ladurner G
Padiatr Padol; 1981; 16(4):481-8. PubMed ID: 6795573
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of atypical absences with a combination of succinimide and dipropylacetate (author's transl)].
Schneble H
Dtsch Med Wochenschr; 1975 Jul; 100(30):1564-7. PubMed ID: 808402
[TBL] [Abstract][Full Text] [Related]
10. Clinical experience with sodium valproate in children.
Leary PM; Morris S
S Afr Med J; 1980 May; 57(21):866-7. PubMed ID: 6773153
[TBL] [Abstract][Full Text] [Related]
11. [Clinical trial od Di-n-propylacetate in epileptics with therapy-resistant absences].
Lüdemann G; Cammann R-J ; Knaape H-H
Psychiatr Neurol Med Psychol (Leipz); 1975 Feb; 27(2):101-7. PubMed ID: 812129
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A
Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
[TBL] [Abstract][Full Text] [Related]
13. Drug therapy: Valproic acid.
Koch-Weser J; Browne TR
N Engl J Med; 1980 Mar; 302(12):661-6. PubMed ID: 6766529
[No Abstract] [Full Text] [Related]
14. Juvenile myoclonic epilepsy.
Kibria EM
J Am Osteopath Assoc; 1993 Jan; 93(1):126-8. PubMed ID: 8423123
[TBL] [Abstract][Full Text] [Related]
15. [Combined suxilep-depakine (dipropylacetate) therapy in children with suxilep-resistant pyknolepsy].
Todt H; Wünsche W; Korth G
Kinderarztl Prax; 1977 Apr; 45(4):175-6. PubMed ID: 406476
[No Abstract] [Full Text] [Related]
16. [Clinical study of serum level of dipropylacetic acid sodium (Depakene) by gaschromatography (author's transl)].
Hosokawa K; Kugoh T; Otsuki S
No To Shinkei; 1977 Aug; 29(8):885-90. PubMed ID: 409421
[No Abstract] [Full Text] [Related]
17. Treatment of generalized epilepsies of childhood and adolescence with sodium valproate ("epilim").
Jeavons PM; Clark JE; Maheshwari MC
Dev Med Child Neurol; 1977 Feb; 19(1):9-25. PubMed ID: 403104
[TBL] [Abstract][Full Text] [Related]
18. [Possible uses of Convulsofin liquid in the treatment of pediatric epilepsies].
Klepel H; Koch RD; Tzenow H
Psychiatr Neurol Med Psychol (Leipz); 1986 Mar; 38(3):142-7. PubMed ID: 3086910
[TBL] [Abstract][Full Text] [Related]
19. [Problems in serum-level determination during valproic acid therapy].
Schäfer H; Reith H; Jacobs R; Gabriel KH
Arzneimittelforschung; 1977; 27(6):1215-21. PubMed ID: 332187
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of juvenile myoclonic epilepsy with low-dose sodium valproate].
De Toffol B; Autret A
Rev Neurol (Paris); 1996 Nov; 152(11):708-10. PubMed ID: 9033947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
